UCB downgraded at Barclays as acquisition costs weigh on H1 outlook

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Why is UCB stock sliding today? Hisse Senetleri 0 1
A UCB to acquire Candid Therapeutics for up to $2.2 billion Hisse Senetleri 0 32
A UCB to acquire Candid Therapeutics for up to $2.2 billion Hisse Senetleri 0 23
A ExxonMobil downgraded at Wolfe after recent rally leaves shares fairly valued Hisse Senetleri 0 18
A Spotify stock downgraded by IndeRes on valuation after rally Hisse Senetleri 0 37
A UCB to acquire Neurona Therapeutics for up to $1.15 billion Hisse Senetleri 0 21
A Replimune sinks 57% on second FDA rejection of melanoma drug; stock downgraded Hisse Senetleri 0 14
A Jefferies downgrades UCB, warns of 15% Bimzelx sales hit by 2026 Hisse Senetleri 0 57

Benzer konular

Üst